Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Pfizer’s Dolsten Plans Exit, Ushering In R&D Transition
09 Jul 2024
•
By
Jessica Merrill
Pfizer's Mikael Dolsten is leaving the company • Source: Pfizer
(WENDY BARROWS photography)
More from Leadership
More from Scrip